# FDA Inspection 1171520 - Roswell Park Cancer Institute - May 06, 2022

Source: https://www.keypedia.com/records/fda_inspections/roswell-park-cancer-institute/8337094c-414f-457f-b891-dcd21426208a
Source feed: FDA_Inspections

> FDA Inspection 1171520 for Roswell Park Cancer Institute on May 06, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1171520
- Company Name: Roswell Park Cancer Institute
- Inspection Date: 2022-05-06
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1037543 - 2017-12-06](https://www.keypedia.com/records/fda_inspections/roswell-park-cancer-institute/636a53a8-9a33-401f-85c5-b8e39a917e98)
- [FDA Inspection 865760 - 2014-01-23](https://www.keypedia.com/records/fda_inspections/roswell-park-cancer-institute/f7204b6c-28b1-4349-8bde-098609c45337)

Company: https://www.keypedia.com/companies/roswell-park-cancer-institute/df49003a-f90e-496d-b4c6-d2449cb287dd

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d